Navigation Links
Pilot Therapeutics Announces New Executive Team with Extensive Experience Creating New Health and Nutrition Businesses
Date:10/19/2007

WINSTON-SALEM, N.C., Oct. 19 /PRNewswire/ -- Pilot Therapeutics Inc., a Nutritional Therapeutics Innovation Company, today announced the appointment of Ross Consaul as CEO and Keith Wakeman as President.

"Pilot has always had promising technology and patents in the food, medical food and dietary supplement areas with over 60 issued and pending patents. These new additions will unlock the potential to rapidly move our world class technologies and IP to the marketplace," said Dr. Floyd "Ski" Chilton, Founder and Chief Technology Officer of Pilot Therapeutics Inc.

Ross joins Pilot with over 20 years experience leading New Ventures, R&D, and New Product Development for large and small companies including Bayer, Kellogg, Pizza Hut and Kashi. He was most recently Nutrition General Manager for Bayer BioScience where he was responsible for identifying and creating new health and nutrition businesses for Bayer.

Keith brings over 20 years of management experience in the food and nutrition industry leading Marketing, Innovation and New Ventures organizations for major companies including Kellogg, Keebler and Nabisco. He was most recently President of Cherry Street Innovation LLC, an innovation company he founded to identify and develop new growth platforms through new ventures and brand innovation.

Former President Scott Derks will remain with Pilot as Vice President, Operations.

"Collectively, Ross and Keith have created new businesses generating nearly $3 billion revenue and bring tremendous experience in health and nutrition. We are delighted to welcome them to our team," said Chilton.

Pilot Therapeutics is a Nutritional Therapeutics Innovation Company dedicated to the prevention and treatment of chronic inflammatory diseases. Through its Functional Liponomics(TM) discovery platform, Pilot examines the influence of fatty acids on the expression of genes that control the inflammatory and allergic process. Utilizing this technology Pilot has developed a pipeline of medical foods for the prevention and treatment of numerous chronic inflammatory disorders in humans and animals. These innovative products are based on over 60 issued and pending domestic and international patents.

Pilot Therapeutics was founded by Chilton, professor of physiology and pharmacology at Wake Forest University School of Medicine. Chilton is also director of the Wake Forest and Brigham and Women's Program for Botanical Lipids which is supported by a $7.5 million grant from the National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements.


'/>"/>
SOURCE Pilot Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. RFID pilot project aims to improve blood banks
2. Pilot fund brings capital to Eau Claire area innovations
3. National $100m pilot program to begin mapping cancer genome
4. Milwaukee health provider network pilots software plan
5. Gateway Technical College pilots IBM training program
6. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
7. Speaker announces business members of IT Task Force
8. Doyle announces technology tax credits for Berbee
9. Doyle announces new energy, global warming policies
10. Doyle announces $80M renewable energy strategy
11. GE announces first installation of Discovery VCT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... BioMedGPS announces expanded coverage of SmartTRAK Business ... US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and Sealants module ... and biologic sealants used in surgical applications. BioMedGPS estimates the market will grow ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
Breaking Biology Technology:
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
Breaking Biology News(10 mins):